“nonalcoholic-steatohepatitis” Archives

in
Entry Author Date Location
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More 10/02/20 National
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries 10/01/20 Europe
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25% 09/01/20 New York
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
FDA Lifts CymaBay Drug Hold, Tests to Resume in Rare Liver Disease PBC 07/23/20 San Francisco
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
FDA Says “No” to Intercept Pharma’s NASH Drug, Asks for More Data 06/29/20 New York
Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More 06/19/20 National
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia 06/11/20 Boston
NodThera Adds $55M to Advance Drugs to Better Regulate Inflammation 06/03/20 Boston
Pliant Therapeutics Prices IPO, Lands $144M to Test Fibrosis Drugs 06/03/20 San Francisco
Pliant Pushes Forward With IPO Plans to Back Fibrosis Drug Studies 05/12/20 San Francisco
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Akero Heads to Top of Class in NASH; Genfit Says Pandemic Won’t Delay Data 04/10/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
Quench Bio Springs From Atlas With $50M for a New Take on Inflammation 01/27/20 Boston
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs 01/10/20 Boston
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate 11/08/19 National
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Viscient Bio Proposes Organovo Merger to Tackle NASH and Go Beyond 10/02/19 San Diego
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More 09/27/19 National
Enanta Steps Forward in NASH Race, With Unclear Prospects 09/26/19 Boston
Novartis & IFM Team Up Again, With Buyout Option for Autoimmune R&D 09/05/19 Boston
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Page 1 of 4 next page »